Blockchain Registration Transaction Record
PainReform Advances Non-Opioid Pain Relief Solution PRF-110 in Phase 3 Trial to Combat Opioid Crisis
PainReform CEO Ilan Hadar discusses the company's innovative non-opioid pain treatment PRF-110 and its potential to combat the opioid crisis. Learn about the Phase III study and the impact of PRF-110 on pain management post-surgery.
The development of PRF-110 by PainReform has the potential to significantly impact pain management practices post-surgery and address the opioid crisis in the United States. If successful, PRF-110 could provide patients with a safer and more effective alternative to traditional opioids, leading to improved patient outcomes and reduced reliance on addictive pain medications.
| Blockchain | Details |
|---|---|
| Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
| Transaction ID | 0x2616cd56838886dfe0fb751b82cef38efa00111c999463d893ed4316fcac6691 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | divebT9o-f0cf187445960e66f1d2efc5fd5002be |